Skip to main content
Loading

Challenges of using single domain antibodies as new modalities of multifunctional biologics

22 Sep 2025
Formats & Scaffolds
  • How can cost and efficiency be balanced in the discovery of optimal SDAbs for use in multifunctional biologics?
  • What is the optimal overall architecture and placement of SDAbs within a multifunctional biologic?
  • How do the complex valency and architecture of SDAb-containing multispecifics affect their functional properties?
Industry Expert
Andrew Peterson, Director - Akiiwan Therapeutics